Anzeige
Mehr »
Donnerstag, 25.09.2025 - Börsentäglich über 12.000 News
Geheime Börsenchance: Ist das die bedeutendste Kupferentdeckung Kanadas?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DWPU | ISIN: US91381U2006 | Ticker-Symbol: 9U90
Stuttgart
25.09.25 | 08:51
0,051 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
UNITY BIOTECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
UNITY BIOTECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur UNITY BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrUnity Biotechnology, Inc. - 8-K, Current Report3
UNITY BIOTECHNOLOGY Aktie jetzt für 0€ handeln
06.08.NSE - Unity Biotechnology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities16
22.07.Unity Biotechnology, Inc. - 8-K, Current Report4
30.06.Unity Biotechnology stock plunges after Nasdaq delisting notice34
30.06.Unity Biotechnology-Aktie stürzt nach NASDAQ-Delisting-Ankündigung ab50
30.06.Unity Biotechnology, Inc. - 8-K, Current Report14
20.06.Unity Biotechnology, Inc. - 8-K, Current Report2
27.05.Unity Biotech stock rating downgraded at H.C. Wainwright17
16.05.Mizuho cuts Unity Biotech stock rating, slashes price target to $19
05.05.Unity Biotechnology, Inc. - 8-K, Current Report3
01.05.Unity Biotechnology, Inc.: UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting4
23.04.H.C. Wainwright maintains $4 target on Unity Biotech stock5
22.04.Unity Biotechnology GAAP EPS of -$0.43 misses by $0.033
22.04.UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates285SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of...
► Artikel lesen
22.04.Unity Biotechnology, Inc. - 10-Q, Quarterly Report3
22.04.Unity Biotechnology, Inc. - 8-K, Current Report2
11.04.Unity Biotechnology, Inc. - 10-K/A, Annual Report1
24.03.Unity Biotechnology, Inc.: UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema294Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidence...
► Artikel lesen
10.03.Unity Biotechnology, Inc.: UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors249SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today...
► Artikel lesen
07.03.UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates392SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3